14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.31 $2.47 Tuesday, 23rd Apr 2024 AKBA stock ended at $1.37. This is 0.735% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 4.44% from a day low at $1.35 to a day high of $1.41.
90 days $1.31 $2.47
52 weeks $0.650 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Mar 18, 2024 $1.76 $2.05 $1.70 $1.89 9 467 683
Mar 15, 2024 $1.60 $1.82 $1.52 $1.70 13 482 326
Mar 14, 2024 $1.43 $1.43 $1.34 $1.37 2 435 516
Mar 13, 2024 $1.45 $1.50 $1.41 $1.41 2 054 291
Mar 12, 2024 $1.45 $1.45 $1.36 $1.42 3 348 839
Mar 11, 2024 $1.52 $1.55 $1.43 $1.44 3 146 006
Mar 08, 2024 $1.49 $1.57 $1.45 $1.47 2 372 773
Mar 07, 2024 $1.50 $1.56 $1.46 $1.46 2 194 059
Mar 06, 2024 $1.64 $1.64 $1.46 $1.49 3 937 777
Mar 05, 2024 $1.60 $1.66 $1.58 $1.60 1 932 063
Mar 04, 2024 $1.77 $1.79 $1.61 $1.62 3 016 658
Mar 01, 2024 $1.57 $1.71 $1.57 $1.71 3 447 663
Feb 29, 2024 $1.58 $1.63 $1.54 $1.58 1 962 274
Feb 28, 2024 $1.68 $1.68 $1.54 $1.54 2 494 931
Feb 27, 2024 $1.51 $1.68 $1.48 $1.64 4 187 589
Feb 26, 2024 $1.38 $1.54 $1.37 $1.51 2 827 220
Feb 23, 2024 $1.40 $1.40 $1.32 $1.35 3 039 348
Feb 22, 2024 $1.46 $1.47 $1.38 $1.39 2 301 911
Feb 21, 2024 $1.46 $1.48 $1.41 $1.42 1 797 076
Feb 20, 2024 $1.46 $1.51 $1.42 $1.44 2 466 531
Feb 16, 2024 $1.45 $1.48 $1.43 $1.45 1 890 408
Feb 15, 2024 $1.53 $1.54 $1.40 $1.47 3 519 674
Feb 14, 2024 $1.55 $1.58 $1.52 $1.53 1 405 086
Feb 13, 2024 $1.62 $1.63 $1.50 $1.52 2 096 620
Feb 12, 2024 $1.62 $1.67 $1.61 $1.62 1 853 606
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT